-
Sometimes it takes someone from outside the research field to come up with a clinical trial (CT) solution that is logical, effective, and successful.
-
Sometimes it's the little things in the clinical trial (CT) process that can cause the biggest problems down the road.
-
A good way to find weak areas in clinical trials (CT) research is by gathering information through a quality improvement (QI) program about what CT sites have done wrong.
-
Clinical trial (CT) sites should be providing research nurses and other staff with the best possible foundation in clinical research ethics, as well as helping them make the transition from clinical care to research trials, experts say.
-
One ethical dilemma nurses face when they move from clinical care to clinical research is the way the two fields' missions are different with regard to patients.
-
-
When a judge recently ordered a pharmaceutical company to provide an investigational drug to a teenage boy who had not met the enrollment criteria for a phase II trial, the IRB world took note.
-
Decision making in health care ethics consultation cases often involves difficult, complex issues and mediating differences of opinion.
-
Bridges to Excellence (BTE) CEO Francois de Brantes doesn't mince words when asked if he thinks there is an ethical conflict between the payment model of pay-for-performance essentially giving physicians additional payments for good performance based on certain quality measures and ethical decision-making by physicians.
-
More and more questionable ties between physicians and drug companies are being uncovered in an investigation into such financial relationships conducted by Sen. Charles Grassley (R-IA).